Search results for: 'medicine ad regenerative'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...

This research service focuses on the North American nuclear medicine equipment market, specifically SPECT and SPECT/CT systems. The research service covers the markets for these systems over a eleven year period, from 2004 to 2014, with the base year being 2007. The research service provides a comprehensive analysis and forecasts for revenue by s...

18 Jan 2017  |  North America  |  Market Research

Global Precision Medicine Growth Opportunities, Forecast to 2025

Strategies and Tactics for Accelerating Growth in a Transforming Market

Infographics

×

Precision medicine aims to integrate personalized health data both from direct (quantifiable) and indirect (quantifiable) sources probing the deepest mysteries affecting individual health and well-being. Rising pressures to decrease healthcare cost globally, emergence of value-based reimbursement models, and healthcare digitization trends are trans...

This research service pertains to the US market for nuclear medicine and positron emission tomography (PET) imaging systems. Providing thorough market sizing and forecast of market revenue, unit shipments, procedure volumes, average pricing, and installed base, the study analyzes market trends, drivers and restraints, along with the reimbursement a...

Both predictive and prognostic biomarkers constitutes an central element in each and every targeted oncology drug discovery and development program. Breakthrough technologies allowing leveraging biomarkers for oncology are paving the way of personalized medicine and precision oncology. Indeed, oncology biomarkers provide the clinical community with...

The evolution in autonomy and increase in the adoption of driver assistance systems have generated a need to sense and perceive the surrounding environment of a vehicle entirely and accurately. The fusion of forward-looking sensor data has given OEMs and Tier-I suppliers opportunities to offer multiple ADAS applications at low costs, while providin...

Major automotive OEMs globally are now incorporating active safety and automated vehicle technologies in their future vehicle line-ups to enhance safety and driver comfort. To gauge the suitability of each technology, continuous testing and validation is a must. Based on supportive legislation, several regions across the globe have been identified ...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...